该文报道1 例α1 抗胰蛋白酶Pittsburgh 突变患儿。患儿男,因反复膝关节血肿就诊,凝血功能检查提示凝血活酶时间、部分凝血活酶时间均延长,1:1 血浆纠正试验仅能部分纠正,凝血因子Ⅷ抑制物、抗心磷脂抗体、狼疮抗凝物为阴性,凝血酶诱导的血小板聚集试验提示血液中存在凝血酶抑制物,基因检测证实为Pittsburgh 突变导致α1 抗胰蛋白酶突变。该文结合文献,总结和分析了α1 抗胰蛋白酶Pittsburgh 突变所导致出血的临床特点、诊断和治疗。
Abstract
The study reports a boy with alpha1-antitrypsin Pittsburgh mutation. The boy was admitted into the hospital because of recurrent joint hematoma. The laboratory examinations revealed that prothrombin time and activated partial thromboplastin time were prolonged and cannot be corrected by 1:1 fresh plasma. The inhibitor of factor VIII, anticardiolipin antibody and lupus anticoagulant were all negative. Platelet aggregation test indicated the existence of the inhibitor of thrombin. Alpha1-antitrypsin Pittsburgh mutation was confirmed by genomic sequencing. The clinical manifestations, diagnosis and treatment of this disorder are discussed in this paper.
关键词
出血性疾病 /
α1 抗胰蛋白酶 /
Pittsburgh 突变 /
儿童
Key words
Bleeding disease /
α1-antitrypsin /
Pittsburgh mutation /
Child
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] Lewis JH, Iammarino RM, Spero JA, et al. Antithrombin Pittsburgh: an alpha1-antitrypsin variant causing hemorrhagic disease[J]. Blood, 1978, 51(1): 129-137.
[2] Hua B, Fan L, Liang Y, et al. Alpha1-antitrypsin Pittsburgh in a family with bleeding tendency[J]. Haematologica, 2009, 94(6): 881-884.
[3] Emmerich J. Alpha1-antitrypsin and the maintenance of hemostatic balance[J]. Haematologica, 2009, 94(6): 762-763.
[4] Schapira M, Ramus MA, Jallat S, et al. Recombinant alpha 1-antitrypsin Pittsburgh (Met 358—Arg) is a potent inhibitor of plasma kallikrein and activated factor XII fragment[J]. J Clin Invest, 1986, 77(2): 635-637.
[5] Heeb MJ, Bischoff R, Courtney M, et al. Inhibition of activated protein C by recombinant alpha 1-antitrypsin variants with substitution of arginine or leucine for methionine358[J]. J Biol Chem, 1990, 265(4): 2365-2369.
[6] Scott CF, Carrell RW, Glaser CB, et al. Alpha 1-antitrypsin-Pittsburgh: a potent inhibitor of human plasma factor XIa, kallikrein, and factor XIIf[J]. Trans Assoc Am Physicians, 1985, 98: 344-351.
[7] Owen MC, Brennan SO, Lewis JH, et al. Mutation of antitrypsin to antithrombin. alpha 1-antitrypsin Pittsburgh (358 Met leads to Arg), a fatal bleeding disorder[J]. N Engl J Med, 1983, 309(12): 694-698.
[8] Vidaud D, Emmerich J, Alhenc-Gelas M, et al. Met 358 to Arg mutation of alpha 1-antitrypsin associated with protein C deficiency in a patient with mild bleeding tendency[J]. J Clin Invest, 1992, 89(5): 1537-1543.
[9] Emmerich J, Alhenc-Gelas M, Gandrille S, et al. Mechanism of protein C deficiency in a patient with arginine 358 alpha 1-antitrypsin (Pittsburgh mutation): role in the maintenance of hemostatic balance[J]. J Lab Clin Med, 1995, 125(4): 531-539.
PDF(865 KB)
